Esophageal Cancer Research and Treatment
Peer reviewed
Scollr summary
What this paper is about
Esophagectomy may be feasible in highly selected stage IV patients, offering meaningful survival in stage IV-A cases, while outcomes in stage IV-B remain limited and influenced by metastatic pattern.
Full abstract
Read the full abstract
Objective: This study aimed to assess short- and long-term outcomes in patients undergoing surgery for pathological stage IV esophageal cancer. Background Data: Esophageal cancer has a very poor prognosis in advanced stages, with 5-year survival rates below 6% in stage IV disease. Although current guidelines generally discourage surgery in metastatic patients, selected cases with oligometastatic disease may benefit from esophagectomy within a multimodal treatment framework. Methods: We retrospectively reviewed a prospectively maintained database of 437 esophagectomies performed between January 2013 and June 2024. Sixty patients with pathological stage IV esophageal carcinoma (AJCC 8th edition) were included, including adenocarcinoma, squamous cell carcinoma, and undifferentiated tumors. Patients were divided into stage IV-A ( n = 39) and stage IV-B ( n = 21), all of whom were oligometastatic according to the OMEC classification. The primary endpoints were overall survival (OS) and disease-free survival (DFS). Results: Median age was 63.5 years, and 61.7% of patients were male. Neoadjuvant chemoradiotherapy was administered in 48.3% of cases. Postoperative morbidity was 43.3%, and in-hospital mortality rate of 5%, showing no significant differences between groups. Median OS was significantly longer in stage IV-A compared with stage IV-B (18.0 versus 8.0 months, P = .003), as was median DFS (10.0 versus 3.0 months, P = .010). Among stage IV-B patients, survival differed according to metastatic site, with better outcomes in nodal-only disease. Conclusion: Esophagectomy may be feasible in highly selected stage IV patients, offering meaningful survival in stage IV-A cases, while outcomes in stage IV-B remain limited and influenced by metastatic pattern.
Direct answer
What can I do from this paper page?
Use this page to scan "Stage IV Esophageal Cancer: Room for Improvement?" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Esophageal Cancer Research and Treatment, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Milito2026Stage,
title = {Stage IV Esophageal Cancer: Room for Improvement?},
author = {Pamela Milito and Stefano Siboni and Séréna Grimaldi and Pietro Masseria and Daniele Bernardi and Matteo Melloni and Valentina Milani and E Asti},
journal = {Journal of Laparoendoscopic & Advanced Surgical Techniques},
year = {2026},
doi = {10.1177/10926429261486385},
url = {https://doi.org/10.1177/10926429261486385}
}FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Esophageal Cancer Research and Treatment papers?
Follow Esophageal Cancer Research and Treatment in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Stage IV Esophageal Cancer: Room for Improvement?. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app